Boostrix NDC 58160-842

NDC codes

FDA NDC Directory

Product NDC (as listed)58160-842Labeler and product segments. Claims need a package NDC.

Product NDC at billing width58160-0842Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
58160-842-52	58160084252	10 SYRINGE in 1 CARTON (58160-842-52) / .5 mL in 1 SYRINGE (58160-842-43)Marketed from Jul 24, 2009

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Boostrix
Generic name (nonproprietary): tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed
Active ingredients: Clostridium tetani toxoid antigen (Formaldehyde inactivated) — 5 [iU]/.5mLCorynebacterium diphtheriae toxoid antigen (Formaldehyde inactivated) — 2.5 [iU]/.5mLBordetella pertussis toxoid antigen (Formaldehyde, Glutaraldehyde inactivated) — 8 ug/.5mLBordetella pertussis filamentous hemagglutinin antigen (Formaldehyde inactivated) — 8 ug/.5mLBordetella pertussis pertactin antigen (Formaldehyde inactivated) — 2.5 ug/.5mL
Dosage form: Suspension
Route: Intramuscular
Labeler: GlaxoSmithKline Biologicals SA
Product type: Vaccine
Marketing category: BLA — Biologics License ApplicationApplication BLA 125106
Marketing start: Jul 24, 2009
Listing expires: Dec 31, 2027
Other FDA classes: Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Diphtheria Toxoid (Chemical structure)Pertussis Vaccine (Chemical structure)Pertussis Vaccine (Chemical structure)Pertussis Vaccine (Chemical structure)Tetanus Toxoid (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)
Identifiers: Product ID 58160-842_0ef1de88-4647-4f2d-a6cf-01777f9ccb17SPL ID 0ef1de88-4647-4f2d-a6cf-01777f9ccb17
Pharmacologic class: Inactivated Bordetella Pertussis Vaccine; Inactivated Clostridium Tetani Vaccine; Inactivated Corynebacterium Diphtheriae Vaccine

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Immunization administration (CPT 90460–90474)

Giving a vaccine is reported separately from the vaccine product code, with an immunization administration code. Which code applies depends on the patient's age, the route and whether counselling was provided.

How CPT relates to drug billing

NDC on a medical claim

N458160084252 followed by a unit qualifier and the quantity

Package 58160-0842-52. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

Other NDCs under BLA 125106

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under BLA 125106
Product	Strength	Form · route	Labeler	Product NDC
Boostrixtetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed	Clostridium tetani toxoid antigen (Formaldehyde inactivated) 5 [iU]/.5mL + 4 more ingredients	SuspensionIntramuscular	A-S Medication Solutions	50090-1377